Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings?
The Zacks Consensus Estimate for sales and earnings is pegged at $119.1 million and 16 cents per share, respectively. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Earnings estimate for 2025 has increased to 71 cents from 69 cents per share over the past 60 days, and the same for 2026 has improved to 93 cents from 87 cents.
Zacks Investment Research
Image Source: Zacks Investment Research
ADMA's Earnings Surprise History
ADMA has a mixed track record. Its earnings beat estimates in three of the trailing four quarters and missed in the remaining one, delivering an average surprise of 32.8%. However, in the previously reported quarter, the company's earnings missed estimates by 6.67%.
Zacks Investment Research
Image Source: Zacks Investment Research
What Our Model Predicts for ADMA
Per our proven model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat.
Earnings ESP for ADMA is 0.00%. The company currently carries a Zacks Rank #2. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.
Factors Influencing ADMA's Q1 Results
ADMA Biologics markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases.
The company's top line currently comprises sales of three FDA-approved products, which are Bivigam (an Intravenous Immune Globulin [IVIG] product to treat primary humoral immunodeficiency), Asceniv (to treat primary immunodeficiency disease or PIDD) and Nabi-HB (to treat and provide enhanced immunity against the hepatitis B virus).
Asceniv, its lead product, is a plasma-derived IVIG that contains naturally occurring polyclonal antibodies.
These antibodies are proteins used by the body's immune system to neutralize microbes, such as bacteria and viruses, and prevent infection and disease.
Asceniv is indicated for the treatment of PIDD or inborn errors of immunity in adults and adolescents. It is manufactured using ADMA's unique, patented plasma donor screening methodology and tailored plasma pooling design, which blends normal source plasma with respiratory syncytial virus plasma obtained from donors tested using the company's proprietary microneutralization assay.
Increased sales of Asceniv have likely fueled the top line in the first quarter. Gross margin has also likely improved due to a significantly more favorable mix of high margin immunoglobulin (IG) sales.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
CRISPR and Lab-on-a-Chip Technologies Set to Revolutionize Pathogen Detection
The Global Food Pathogen Testing Market, valued at USD 10 billion in 2025, is projected to grow at a CAGR of 10%, reaching USD 23.5 billion by 2034. Growing food safety concerns and advancements in rapid testing methods, AI, and blockchain are driving this expansion, optimizing food supply chain transparency. Food Pathogen Testing Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "Food Pathogen Testing Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges" report has been added to Food Pathogen Testing Market is valued at USD 10 billion in 2025. Further, the market is expected to grow at a CAGR of 10% to reach USD 23.5 billion by 2034. The Food Pathogen Testing Market is expanding rapidly as global food safety concerns continue to intensify. With rising instances of foodborne illnesses and outbreaks caused by bacteria such as Salmonella, Listeria, and E. coli, food manufacturers and regulatory authorities are prioritizing stringent testing protocols. Food pathogen testing plays a crucial role in ensuring the safety and quality of food products by detecting harmful microorganisms at various stages of production, processing, and distribution. Regulatory frameworks across regions, including the FDA's Food Safety Modernization Act (FSMA) in the U.S. and the European Union's strict food safety directives, are pushing companies to adopt advanced testing in rapid testing methods, including polymerase chain reaction (PCR) and immunoassay-based techniques, are enabling faster and more accurate pathogen detection. Additionally, the growing consumption of processed and packaged foods, along with increased global trade in perishable goods, is further propelling market demand. As food safety regulations become stricter worldwide, investment in food pathogen testing technologies and automation is expected to grow 2024, the Food Pathogen Testing Market has witnessed several key advancements driven by the growing emphasis on foodborne disease prevention. The demand for rapid and automated testing solutions has increased, with food manufacturers investing in next-generation molecular diagnostics and biosensors to achieve quicker turnaround times. AI-driven predictive analytics are being integrated into testing processes to enhance contamination risk assessments and prevent outbreaks before they occur. Regulatory bodies worldwide have intensified surveillance and enforcement, leading to a higher rate of recalls and penalties for expansion of microbiological testing services in developing economies, particularly in Asia-Pacific and Latin America, has also gained momentum due to increased food exports and a growing middle-class population demanding higher food safety standards. Meanwhile, the adoption of blockchain technology in food supply chains is improving traceability and ensuring transparency in pathogen testing, allowing for swift action in case of contamination. The market is also experiencing a shift toward portable testing kits that enable on-site detection, reducing dependency on centralized ahead to 2025 and beyond, the Food Pathogen Testing Market is expected to see further advancements in automation, precision, and regulatory alignment. AI and machine learning will play a more significant role in predictive food safety monitoring, helping manufacturers identify contamination risks before they escalate into widespread issues. The development of CRISPR-based diagnostics is set to revolutionize pathogen detection by providing ultra-sensitive and rapid testing solutions. Additionally, the rise of lab-on-a-chip technology will enable decentralized testing, making food safety monitoring more accessible and the increasing focus on sustainability, manufacturers will also seek eco-friendly testing solutions that minimize chemical waste and energy consumption. Governments and international organizations will likely standardize food safety regulations further, ensuring consistency across borders and streamlining compliance processes. As food production scales up to meet global demand, investments in robust pathogen testing infrastructure will become essential for ensuring public health and maintaining consumer trust in food Trends in the Food Pathogen Testing Market Adoption of AI and Big Data Analytics: AI-driven predictive modeling is being integrated into pathogen testing to analyze contamination patterns, optimize food safety protocols, and minimize risks before they lead to outbreaks. Rise of Rapid and Portable Testing Solutions: The demand for on-site pathogen testing kits is increasing, enabling food manufacturers and regulators to conduct immediate contamination assessments and reduce response times. Integration of Blockchain in Food Safety: Blockchain technology is enhancing traceability and transparency in food supply chains, ensuring accurate record-keeping and quick identification of contamination sources. Expansion of CRISPR-Based Pathogen Detection: Emerging CRISPR diagnostic technologies are offering ultra-fast and precise detection of harmful foodborne pathogens, promising a new era of molecular food safety testing. Growth of Outsourced Testing Services: Many food companies are partnering with third-party laboratories for pathogen testing, ensuring compliance with evolving regulatory requirements while reducing in-house testing costs. Key Market Drivers Increasing Foodborne Illness Outbreaks: Rising global cases of foodborne diseases are driving the demand for stringent pathogen testing measures to ensure consumer safety and prevent large-scale outbreaks. Stringent Government Regulations: Enhanced regulatory frameworks across regions are compelling food manufacturers to comply with mandatory pathogen testing standards, increasing market growth. Surge in Packaged and Processed Food Consumption: The growing consumption of ready-to-eat and processed foods necessitates rigorous testing to ensure microbiological safety and extend shelf life. Technological Advancements in Testing Methods: Innovations in molecular diagnostics, biosensors, and AI-powered analytics are improving pathogen detection efficiency, making testing faster and more reliable. Key Market Challenge High Cost of Advanced Testing Technologies: The implementation of sophisticated pathogen testing solutions, such as molecular diagnostics and AI-driven analytics, involves significant investment, posing challenges for small and mid-sized food businesses. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $10 Billion Forecasted Market Value (USD) by 2034 $23.5 Billion Compound Annual Growth Rate 10.0% Regions Covered Global Companies Featured Bureau Veritas SA Lloyd's Register Quality Assurance Limited Intertek Group plc Asurequality Ltd. Genevac Ltd. Thermo Fisher Scientific Inc. Bio-Rad Laboratories Inc. Merck Co. & KGaA Neogen Corporation bioMerieux SA Agilent Technologies Inc. Qiagen NV Shimadzu Corporation SGS Societe Generale de Surveillance SA Genetic Id Na Inc. RapidBio Systems Inc. Merieux NutriSciences Corp. FoodChain ID Inc. Ring Biotechnology Co. Ltd. Genon Laboratories Ltd. PerkinElmer Inc. Randox Food Diagnostics Ltd. Omega Diagnostics Group plc Romer Labs Inc. Eurofins Scientific SE Charm Sciences Inc. Hygiena LLC MilliporeSigma Hardy Diagnostics Luminex Corporation Market Segmentation By Type Salmonella Listeria Other Pathogens By Technology Traditional Rapid Immunoassay Convenience Based PCR Other Technologies By Application Meat And Poultry Fruits And Vegetables Dairy Other Applications By Sales Channel OEM Aftermarket By Geography North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Food Pathogen Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Rapid and Portable Testing Solutions Gain Traction, Next-Gen Biosensors Revolutionizing Pathogen Detection
The global Food Diagnostics Market is projected to grow from USD 16.2 billion in 2025 to USD 29.9 billion by 2034, with a CAGR of 7.1%. Growing food safety concerns and technological innovations in diagnostics are driving demand. Key trends include AI-driven analytics, portable testing, and blockchain integration. Food Diagnostics Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "Food Diagnostics Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges" has been added to offering. The global Food Diagnostics Market is projected to rise from USD 16.2 billion in 2025 to USD 29.9 billion by 2034, reflecting a CAGR of 7.1%. This growth underscores the market's critical role in maintaining food safety, quality, and regulatory compliance worldwide. As concerns about foodborne illnesses and contamination grow, the adoption of food diagnostics solutions such as testing kits and real-time monitoring systems is expanding. Advanced techniques like PCR-based pathogen detection, immunoassays, and chromatography are increasingly used to detect contaminants, allergens, and toxins in food products. Regulatory agencies like the FDA, EFSA, and WHO are implementing stricter safety regulations, compelling food manufacturers to invest in comprehensive testing protocols. This regulatory push, alongside globalization in food trade, necessitates robust diagnostic solutions to comply with international standards. The Food Diagnostics Market has recently experienced advancements in pathogen detection and contamination analysis. Rapid testing solutions offering quicker and more accurate results are gaining traction among food manufacturers. The growing demand for point-of-care and portable diagnostic devices facilitates on-site testing in various stages of the supply chain. Blockchain technology is also being integrated to offer enhanced traceability and transparency, allowing effective contamination tracking. Looking toward 2025 and beyond, the market is poised for transformative change fueled by emerging technologies and evolving regulations. AI and machine learning will enhance predictive analytics for early contamination risk detection. Automated diagnostic platforms incorporating robotics and smart data analytics will improve testing efficiency and accuracy. Blockchain-powered traceability solutions are expected to gain traction, offering comprehensive farm-to-fork transparency. Innovations in biosensor and lab-on-a-chip technology will revolutionize food diagnostics by providing real-time, sensitive contaminant detection. The Asia-Pacific region is projected to witness significant market growth due to rising food safety concerns, governmental regulations, and rapid industrialization in the food processing sector. As the demand for organic and clean-label products increases, stringent testing protocols will become essential to maintain consumer trust and adhere to global safety standards. Key Market Trends AI and Machine Learning in Food Testing: Predictive analytics transform diagnostics by optimizing risk detection and testing processes. Rise of Rapid and Portable Testing Solutions: Handheld devices allow real-time product testing beyond complex lab setups. Blockchain for Enhanced Traceability: Integration improves supply chain transparency and contamination source identification. Next-Generation Biosensors: New technologies enable rapid and sensitive detection of hazards in food samples. Expansion of Automated and Robotics-Based Testing: Automation reduces errors and enhances testing workflows. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $16.2 Billion Forecasted Market Value (USD) by 2034 $29.9 Billion Compound Annual Growth Rate 7.1% Regions Covered Global Companies Featured Randox Food Diagnostics 3M Company Shimadzu Corporation Thermo Fisher Scientific Inc. PerkinElmer Inc. Agilent Technologies Inc. Neogen Corporation FOSS India Private Limited bioMerieux SA Danaher Corporation Bio-Rad Laboratories Inc. Biorex Food Diagnostics Merck KGaA QIAGEN N.V. ALS Limited Intertek Group plc Hygiena LLC EnviroLogix Inc. AsureQuality Limited Bruker Corporation Covance Inc. EMSL Analytical Inc. Eurofins Scientific SE FoodChain ID Pty. Ltd. Merieux NutriSciences Corporation Microbac Laboratories Inc. Romer Labs Division Holding GmbH Charm Sciences Inc. SGS North America Inc. Silliker Inc. Symbio Laboratories Pty. Ltd. TUV SUD AG For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Food Diagnostics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900登入存取你的投資組合
Yahoo
3 hours ago
- Yahoo
GE HealthCare's Vizamyl Receives Expanded FDA Approval for Quantitative Alzheimer's Amyloid Detection
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best up and coming stocks to invest in now. On June 24, On June 24, 2025, GE HealthCare announced that the US FDA approved an updated label for its Vizamyl (flutemetamol F 18 injection) PET imaging agent, which is used for beta-amyloid detection. The immediate update expands the agent's indications, which allows for quantitative analysis of Vizamyl scans, and removes several prior limitations. Previously, amyloid diagnostics like Vizamyl provided a visual assessment of amyloid plaque in the brain. With the new label, clinicians can now use quantitative analysis software to objectively calculate amyloid load. A radiologist in a lab examining a computed tomography scan of a patient. The removal of the therapy monitoring limitation means Vizamyl can now be used to determine if amyloid plaque levels have sufficiently reduced to consider discontinuing therapy. The updated label also explicitly indicates Vizamyl's use for selecting patients eligible for anti-amyloid therapy. Vizamyl was initially approved in 2013 to estimate beta-amyloid neuritic plaque density in adults with cognitive impairment. GE HealthCare Technologies Inc. (NASDAQ:GEHC) develops, manufactures, and markets products, services, and digital solutions used in the diagnosis, treatment, and monitoring of patients. While we acknowledge the potential of GEHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
